AP. Alltracel PH.

    


Loeb Partners Corporation

Ap 9
Appendix 3 Disclosure Forms

Page 1 of 4 FORM 8.1/8.3 IRISH TAKEOVER PANEL

Date of disclosure......March 19, 2008

Lodge with the Stock Exchange (which may publicise) and with the Panel. Use
separate form for each class of securities in which dealings have been made.

DISCLOSURE UNDER RULE 8.1(a), 8.1(b)(i) and 8.3 OF THE IRISH TAKEOVER PANEL ACT,
                           1997, TAKEOVER RULES, 2007

Date of Dealing ............................March 18, 2007

Dealing in (name of company)......Alltracel Pharmaceuticals Plc

(1) Class of securities (e.g. ordinary shares) ordinary shares (via Swap)

(2) Amount bought 50,000

Amount sold

Price per unit 12.85 GBp

(4) Party making disclosure..Loeb Holding Corporation

(3) Resultant total of the same class owned or controlled (and percentage of
class) 1,550,000.......................................1.20% (%)

(5) EITHER (a) Name of purchaser/vendor (Note 1) OR (b) If dealing for
discretionary client(s), name of fund management organisation

Loeb Holding Corporation

(6) Reason for disclosure (Note 2)

YES/NO(a) (i) offeror or associate of offeror (Note 3)

YES/NO(ii) offeree or associate of offeree Specify which category or categories
of associate ((a) to (l) page 3/4) ..... If category (l), explain ..........

(b) Rule 8.3 (i.e. disclosure because of ownership or control of 1% or more the
class of relevant securities dealt in) YES/NO

Signed, for and on behalf of the party named in (4) above ../Shelby Drescher/

(Also print name of signatory)........Shelby Drescher
Telephone and extension number........212-483-7070

Alltracel Pharmaceuticals (LSE:AP.)
Gráfica de Acción Histórica
De Abr 2024 a May 2024

Alltracel Pharmaceuticals (LSE:AP.)
Gráfica de Acción Histórica
De May 2023 a May 2024